Cargando…

Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells

Multidrug resistance protein-1 (MDR1) has been proven to be associated with the development of chemoresistance to imatinib (Glivec, STI571) which displays high efficacy in treatment of BCR-ABL-positive chronic myelogenous leukemia (CML). However, the possible mechanisms of MDR1 modulation in the pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Wu, Song, Li, Chen, Xi-Lei, Zeng, Xiang-Feng, Wu, Jian-Zhang, Zhu, Cai-Rong, Huang, Tao, Tan, Xiang-Peng, Lin, Xiao-Mian, Yang, Qi, Wang, Ji-Zhong, Li, Xiao-Kun, Wu, Xiao-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042009/ https://www.ncbi.nlm.nih.gov/pubmed/27050374 http://dx.doi.org/10.18632/oncotarget.8489

Ejemplares similares

The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer
por: Lin, Xiao-mian, et al.
Publicado: (2019)

Lysosome-mediated chemoresistance in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2022)

Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
por: Alimu, Xierenguli, et al.
Publicado: (2023)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis
por: Zhu, Xi, et al.
Publicado: (2010)

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke
por: He, Xin-Wei, et al.
Publicado: (2017)

MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance
por: Yan, Zi-Xun, et al.
Publicado: (2015)

Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
por: Horibata, Sachi
Publicado: (2019)

Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia
por: Shi, Mingyue, et al.
Publicado: (2021)

microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview
por: Gabra, Martino Marco, et al.
Publicado: (2017)

Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
por: Feng, Lili, et al.
Publicado: (2023)

Design, synthesis and pharmacological characterization of N-(3-ethylbenzo[d]isoxazol-5-yl) sulfonamide derivatives as BRD4 inhibitors against acute myeloid leukemia
por: Zhang, Mao-feng, et al.
Publicado: (2022)

Identification and Molecular Characterization of a Chitin Deacetylase from Bombyx mori Peritrophic Membrane
por: Zhong, Xiao-Wu, et al.
Publicado: (2014)

A retrospective assessment of real-world experience with venetoclax and azacitidine therapy in elderly acute myeloid leukemia
por: Hu, Rong-Hua, et al.
Publicado: (2022)

Identification of Circular RNAs Associated With Chemoresistance in Colorectal Cancer
por: Yao, Fei, et al.
Publicado: (2021)

Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2(−/−) acute myeloid leukemia
por: Song, Jiachun, et al.
Publicado: (2021)

Identification of Potential Novel Prognosis-Related Genes Through Transcriptome Sequencing, Bioinformatics Analysis, and Clinical Validation in Acute Myeloid Leukemia
por: Wang, Jie, et al.
Publicado: (2021)

Long non-coding RNA MIR17HG sponges microRNA-21 to upregulate PTEN and regulate homoharringtonine-based chemoresistance of acute myeloid leukemia cells
por: Yan, Jinhua, et al.
Publicado: (2022)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia
por: Johansen, Silje, et al.
Publicado: (2018)

Overexpression miR-520a-3p inhibits acute myeloid leukemia progression via targeting MUC1
por: Chen, Xiao-Yu, et al.
Publicado: (2022)

miR-199a-5p Represses Protective Autophagy and Overcomes Chemoresistance by Directly Targeting DRAM1 in Acute Myeloid Leukemia
por: Li, Yang, et al.
Publicado: (2019)

Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection
por: Caiado, Francisco, et al.
Publicado: (2019)

Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2023)

Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis
por: Ruan, Xiao-Lan, et al.
Publicado: (2015)

The microRNAs involved in human myeloid differentiation and myelogenous/myeloblastic leukemia
por: Wang, Xiao-Shuang, et al.
Publicado: (2008)

Oxidative Stress and ROS-Mediated Signaling in Leukemia: Novel Promising Perspectives to Eradicate Chemoresistant Cells in Myeloid Leukemia
por: Trombetti, Silvia, et al.
Publicado: (2021)

Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells
por: Zhang, Zunyue, et al.
Publicado: (2018)

m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia
por: Liu, Ya, et al.
Publicado: (2023)

Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway
por: Zhang, Jian, et al.
Publicado: (2020)

Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia
por: Hu, Zheng, et al.
Publicado: (2009)

Identification of cellular senescence-related signature for predicting prognosis and therapeutic response of acute myeloid leukemia
por: Zhong, Fangmin, et al.
Publicado: (2023)

Galectin-1 expression in the serum and placenta of pregnant women with fetal growth restriction and its significance
por: Jin, Xiao-Xiao, et al.
Publicado: (2021)

Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia
por: Kamga, Paul Takam, et al.
Publicado: (2016)

Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia
por: Hatzl, Stefan, et al.
Publicado: (2020)

Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3
por: Lu, Hao, et al.
Publicado: (2022)

Low frequency TP53 hotspot mutation contributes to chemoresistance through clonal expansion in acute myeloid leukemia
por: Yan, Bowen, et al.
Publicado: (2020)

MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1
por: Zhou, MinRan, et al.
Publicado: (2013)

Enhanced MCM5 Level Predicts Bad Prognosis in Acute Myeloid Leukemia
por: Wang, Shuming, et al.
Publicado: (2022)

Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia
por: Li, Bing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_crq9mf9v1v614e9t6dc13h3gts